DE69215626T2 - Trimetazidinederivate, Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen - Google Patents
Trimetazidinederivate, Verfahren zu deren Herstellung und deren pharmazeutischen ZusammensetzungenInfo
- Publication number
- DE69215626T2 DE69215626T2 DE69215626T DE69215626T DE69215626T2 DE 69215626 T2 DE69215626 T2 DE 69215626T2 DE 69215626 T DE69215626 T DE 69215626T DE 69215626 T DE69215626 T DE 69215626T DE 69215626 T2 DE69215626 T2 DE 69215626T2
- Authority
- DE
- Germany
- Prior art keywords
- processes
- preparation
- pharmaceutical compositions
- derivatives
- trimetazidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9111469A FR2681324B1 (fr) | 1991-09-18 | 1991-09-18 | Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant. |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69215626D1 DE69215626D1 (de) | 1997-01-16 |
DE69215626T2 true DE69215626T2 (de) | 1997-06-12 |
Family
ID=9417037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69215626T Expired - Fee Related DE69215626T2 (de) | 1991-09-18 | 1992-09-18 | Trimetazidinederivate, Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen |
Country Status (14)
Country | Link |
---|---|
US (1) | US5283246A (de) |
EP (1) | EP0533579B1 (de) |
JP (1) | JPH0676396B2 (de) |
AT (1) | ATE145899T1 (de) |
AU (1) | AU647964B2 (de) |
CA (1) | CA2078520C (de) |
CY (1) | CY2142B1 (de) |
DE (1) | DE69215626T2 (de) |
DK (1) | DK0533579T3 (de) |
ES (1) | ES2097299T3 (de) |
FR (1) | FR2681324B1 (de) |
GR (1) | GR3022322T3 (de) |
NZ (1) | NZ244370A (de) |
ZA (1) | ZA927165B (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5432179A (en) * | 1991-07-19 | 1995-07-11 | Zeria Pharmaceutical Co., Ltd. | Piperazine derivatives and pharmaceuticals containing the same |
FR2703048B1 (fr) * | 1993-03-24 | 1996-01-05 | Adir | Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
ATE214059T1 (de) * | 1994-04-11 | 2002-03-15 | Chugai Pharmaceutical Co Ltd | 4,6-di-t-butyl-2,3-dihydrobenzothiophene, die ldl oxidation hemmen |
IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
US6011046A (en) * | 1995-08-21 | 2000-01-04 | Takeda Chemical Industries, Ltd. | Quinone compound, its production and use as antioxidant |
FR2757164B1 (fr) * | 1996-12-16 | 1999-01-22 | Adir | Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
JPH10265386A (ja) * | 1997-03-21 | 1998-10-06 | Toshio Sato | 抗酸化作用を有する抗アレルギー剤 |
US6608066B1 (en) * | 1999-10-27 | 2003-08-19 | Sunol Molecular Corporation | Tissue factor antagonists and methods of use thereof |
EP1829535A3 (de) * | 1999-10-27 | 2007-10-24 | Tanox, Inc. | Gewebefaktor-Antagonisten und Verfahren zu deren Verwendung |
FR2802424B1 (fr) * | 1999-12-17 | 2002-02-15 | Adir | Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale |
FR2805463B1 (fr) * | 2000-02-25 | 2003-01-24 | Adir | UTILISATION DE LA TRIMETAZIDINE POUR L'OBTENTION DE COMPOSITIONS PHARMACEUTIQUES DESTINEES A INHIBER L'ACYL-CoA ACETYLTRANSFERASE |
FR2827284B1 (fr) * | 2001-07-16 | 2003-10-31 | Servier Lab | Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2003037323A2 (en) * | 2001-10-26 | 2003-05-08 | MEDIGENE AG Gesellschaft für Molekularbiologische Kardiologie und Onkologie | Inhibitors of the fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction |
WO2007116243A2 (en) * | 2006-04-10 | 2007-10-18 | Mintails Limited | Method for treating fibromyalgia and related conditions |
ES2508490T3 (es) | 2010-05-04 | 2014-10-16 | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi | Formulación de trimetazidina con diferentes perfiles de liberación |
CN103554057B (zh) * | 2013-11-13 | 2016-04-20 | 武汉武药科技有限公司 | 曲美他嗪衍生物及其制备方法 |
WO2018093839A1 (en) | 2016-11-15 | 2018-05-24 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Therapy for mitochondrial fatty acid beta-oxidation and transport disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1187706A (en) * | 1968-06-07 | 1970-04-15 | Ciba Ltd | 2-Aminomethyl-2,3-Dihydro-Benzofurans |
US4100285A (en) * | 1976-04-09 | 1978-07-11 | Nippon Shinyaku Co., Ltd. | N-substituted trialkoxybenzyl piperazine derivatives |
EP0202580B1 (de) * | 1985-05-13 | 1990-03-28 | Kuraray Co., Ltd. | 3,4-Dihydrobenzopyranderivate |
WO1987005020A1 (en) * | 1986-02-21 | 1987-08-27 | Kuraray Co., Ltd. | 3,4-dihydro-2h-benzopyran derivatives and their medicinal use |
-
1991
- 1991-09-18 FR FR9111469A patent/FR2681324B1/fr not_active Expired - Fee Related
-
1992
- 1992-09-17 AU AU24537/92A patent/AU647964B2/en not_active Ceased
- 1992-09-17 CA CA002078520A patent/CA2078520C/fr not_active Expired - Fee Related
- 1992-09-17 US US07/946,933 patent/US5283246A/en not_active Expired - Fee Related
- 1992-09-17 NZ NZ244370A patent/NZ244370A/en unknown
- 1992-09-18 JP JP4293636A patent/JPH0676396B2/ja not_active Expired - Fee Related
- 1992-09-18 DE DE69215626T patent/DE69215626T2/de not_active Expired - Fee Related
- 1992-09-18 DK DK92402566.1T patent/DK0533579T3/da active
- 1992-09-18 AT AT92402566T patent/ATE145899T1/de not_active IP Right Cessation
- 1992-09-18 EP EP92402566A patent/EP0533579B1/de not_active Expired - Lifetime
- 1992-09-18 ZA ZA927165A patent/ZA927165B/xx unknown
- 1992-09-18 ES ES92402566T patent/ES2097299T3/es not_active Expired - Lifetime
-
1997
- 1997-01-21 GR GR970400086T patent/GR3022322T3/el unknown
-
1999
- 1999-11-19 CY CY9900038A patent/CY2142B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPH05194451A (ja) | 1993-08-03 |
CA2078520C (fr) | 2001-04-24 |
EP0533579A1 (de) | 1993-03-24 |
CA2078520A1 (fr) | 1993-03-19 |
DE69215626D1 (de) | 1997-01-16 |
EP0533579B1 (de) | 1996-12-04 |
ES2097299T3 (es) | 1997-04-01 |
AU647964B2 (en) | 1994-03-31 |
FR2681324B1 (fr) | 1993-10-29 |
ZA927165B (en) | 1993-03-24 |
AU2453792A (en) | 1993-03-25 |
GR3022322T3 (en) | 1997-04-30 |
US5283246A (en) | 1994-02-01 |
DK0533579T3 (da) | 1997-05-26 |
FR2681324A1 (fr) | 1993-03-19 |
JPH0676396B2 (ja) | 1994-09-28 |
NZ244370A (en) | 1994-09-27 |
ATE145899T1 (de) | 1996-12-15 |
CY2142B1 (en) | 2002-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69215626T2 (de) | Trimetazidinederivate, Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen | |
DE69110625D1 (de) | Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen. | |
DE69111582T2 (de) | 1,4-Disubstituierte Piperazine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen. | |
ATE1288T1 (de) | Amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel. | |
ATE10368T1 (de) | Uracilderivate, verfahren zu ihrer herstellung und eine diese enthaltende pharmazeutische zubereitung. | |
DE69104948T2 (de) | Spiro[4,5]decanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
DE69406853T2 (de) | Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
DE69201480D1 (de) | Ethanolaminbenzoatderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. | |
DE69204474T2 (de) | Benzisoxazole und Benzisothiazolederivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. | |
IL69683A0 (en) | Isoquinoline derivatives,a process for their preparation,pharmaceutical formulations based on these compounds and the use thereof | |
ATE18050T1 (de) | Triazolochinazoline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
DE69104286D1 (de) | Disubstituierte Polymethylenimine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel. | |
DE58907804D1 (de) | Neue basisch substituierte 5-Halogen-Thienoisothiazol-3(2H)-on-1,1-dioxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate. | |
ATE3549T1 (de) | Theophyllin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
ATE13181T1 (de) | Pyridazinonimine und ihre physiologisch vertraeglichen saeureadditionssalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel. | |
ATE115118T1 (de) | Benzoesäureethanolaminesterderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE69403606T2 (de) | Cyclizierte Analoge der Fettsäurenmetaboliten, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR |
|
8339 | Ceased/non-payment of the annual fee |